| atezolizumab based treatment |
| atezolizumab plus carboplatin plus nab-paclitaxel |
es-BC - Triple negatif (TNBC) - (neo)adjuvant (NA) | |
es-BC - TNBC - NA - all population 5 | |
es-BC - TNBC - NA - PDL1 positive 1 | |
Comparator:
vs carboplatin plus nab-paclitaxel;
Risk of bias:
low;
some concerns;
high;
NA;